Searchable abstracts of presentations at key conferences in endocrinology

ea0050p292 | Neuroendocrinology and Pituitary | SFEBES2017

The burden of arthropathy in acromegaly: results from an observational study

Kyriakakis Nikolaos , Lynch Julie , Orme Steve M , Gilbey Stephen G , Conaghan Philip , Murray Robert D

Introduction: Patients with acromegaly are often left with long-term sequelae, among which arthropathy is the most common. Studies have shown impaired quality of life (QoL) in patients with acromegaly, even after long-term remission. Arthropathy is a negative predictive factor of QoL, due to its impact on physical symptoms and functioning.Patients/Methods: To characterise further the extent of the acromegalic arthop...

ea0050p189 | Clinical Biochemistry | SFEBES2017

Diagnosis and management of hyponatraemia in patients with cancer

Grigoriadou Victoria Chatzimavridou , Notarstefano Chiara , Monaghan Philip , Trainer Peter , Higham Claire

Background: Hyponatraemia (most commonly secondary to SIADH) is very common in cancer patients; it is associated with delays to oncology treatment and mortality.Aim: To evaluate the number of patients with hyponatraemia at a tertiary referral cancer centre and assess adherence to national recommendations for investigations and treatment.Methods: All biochemistry results (in-patient and outpatient) analys...

ea0050p286 | Neuroendocrinology and Pituitary | SFEBES2017

Acromegaly complication screening – are we meeting the guidelines?

Sifontes-Dubon Mildred , Bhatt Dhruti , Murray Lynne , Phull Perminder , Graveling Alex , Philip Sam , Abraham Prakash

Aims: Endocrine Society (ES) acromegaly guidelines (2014) addressed complication screening. Uncontrolled acromegaly is associated with elevated cardiovascular mortality due to risk factors including hypertension (HT), diabetes mellitus (DM), obstructive sleep apnoea (OSA), and with an increased risk of colorectal cancer and polyps among other types of neoplasias. We audited our clinical practice with regards to acromegaly complication screening.Methods: ...

ea0050p289 | Neuroendocrinology and Pituitary | SFEBES2017

Treating mild central hypothyroidism in postoperative pituitary patients – impact of Endocrine Society guidelines

Bhatt Dhruti , Sifontes-Dubon Mildred , Graveling Alex , Philip Sam , Abraham Prakash

Aim: Endocrine Society (2016) published guidelines for hormonal replacement in hypopituitarism. Central hypothyroidism (CH) is defined as fT4 below reference range and mild CH is defined as fT4 in the low-normal range with suggestive symptoms in the context of pituitary disease. In patients with panhypopituitarism levothyroxine in doses sufficient to achieve fT4 levels in the upper half of the reference range is recommended. In our centre...

ea0050p292 | Neuroendocrinology and Pituitary | SFEBES2017

The burden of arthropathy in acromegaly: results from an observational study

Kyriakakis Nikolaos , Lynch Julie , Orme Steve M , Gilbey Stephen G , Conaghan Philip , Murray Robert D

Introduction: Patients with acromegaly are often left with long-term sequelae, among which arthropathy is the most common. Studies have shown impaired quality of life (QoL) in patients with acromegaly, even after long-term remission. Arthropathy is a negative predictive factor of QoL, due to its impact on physical symptoms and functioning.Patients/Methods: To characterise further the extent of the acromegalic arthop...

ea0089p10 | Population Science | NANETS2022

Environmental Pollution and GEP-NENS – Is There an Association?

Ituarte, PhD Philip H. G. , MA Nora Ruel , MD Daneng Li , MD Gagandeep Singh

Background: Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NEMs) is increasing, but etiology of sporadic, non-familial disease remains obscure. Behavioral risk factors like smoking and alcohol consumption may be associated with GEP-NENs, yet environmental factors potentially associated with GEP-NENs remain unexamined. We regressed age-adjusted incidence rates for GEP-NENs cases in California (CA) on county-level pollution data to determine if an association ...

ea0090oc9.6 | Oral Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Previous use of anabolic androgenic steroids is associated with persistent impaired myocardial microcirulation

Bulut Yeliz , J. Rasmussen Jon , Brandt-Jacobsen Niels , Lassen Martin Lyngby , Hasbak Philip , Kistorp Caroline

Background and Aim: Ongoing anabolic androgenic steroids (AAS) use has been linked with left ventricle dysfunction, while information on the effects years after discontinuation is limited. Furthermore, the underlying mechanism behind the impaired cardiac function is unknown. Early signs of cardiomyopathy, such as microvascular dysfunction with global or regional reduced myocardial perfusion can be measured noninvasively by cardiac positron emission tomography (PET) with Rubidi...

ea0090ep1009 | Thyroid | ECE2023

50 Shades of Graves’

Newland-Jones Philip , Bujanova Jana , Pilobello Nemia , Bray Diane , Knysak Alicja

Introduction: We present a series of 10 cases of GD presenting with seemingly unrelated symptoms with limited features of thyrotoxicosis, where control of thyroid function tests (TFTs) led to complete normalisation of presenting symptoms. In all cases patients were shown to have Graves disease with thyroid antibodies.Case series review: 1. 82F with symptomatic hypercalcaemia and thymic hyperplasia on CT. Calcium normalised with standard therapy and remai...

ea0065p184 | Metabolism and Obesity | SFEBES2019

Vitamin B12 deficiency leads to fatty acid metabolism dysregulation and increased pro-inflammatory cytokine production in human adipocytes and in maternal subcutaneous and omental adipose tissue

Samavat Jinous , Adaikalakoteswari Antonysunil , Boachie Joseph , Jackisch Laura , McTernan Philip , Christian Mark , Saravanan Ponnusamy

Vitamin B12 (B12) is an essential micronutrient required for several metabolic reactions. Animal and clinical studies show that B12-deficiency is associated with metabolic syndrome. Given the key metabolic role of adipose tissue, we investigated whether B12 deficiency may affect triglyceride synthesis and lipid metabolism leading to adipose tissue inflammation. The AbdSc pre-adipocyte cell line (Chub-S7) and human AbdSc primary pre-adipocytes were differentiated under differen...

ea0065p185 | Metabolism and Obesity | SFEBES2019

Endotoxin and adiposity as mediators of down-regulating the BRITE fat phenotype

Omran Farah , Murphy Alice , Jackisch Laura , Samavat Jinus , McTernan Philip G , Christian Mark

Background: The acquisition of brown-adipocyte-properties by white-adipocytes (BRITE-adipocytes) is an appealing-prospect to combat obesity and type-2-diabetes-Mellitus (T2DM). This may support counteracting the impact of inflammation and mitochondrial-dysfunction, which contribute to the obesity-pathogenesis. However, our previous-finding shave shown that the gut-derived-inflammatory-agent endotoxin can increase the inflammatory-response in white-adipose-tissue impacted by ob...